AbbVie And Genmab A/S Present Two Data Analyses From Clinical Trials Show Epcoritamab Induces Durable Complete Reponses As Monotherapy And Combination Treatment In Patients With Diffuse Large B-Cell Lymphoma; Results From Arm 1 Of The EPCORE NHL-2...
Check Out What Whales Are Doing With ABBV
Monday Market Falls, Chinese Stocks Climb, Indices Rebalance | Live Stock
S&P 500, Nasdaq Pull Back From Record Highs, With Nvidia Under Pressure; Dow Down
A Closer Look at Tesla's Options Market Dynamics
'OpenAI's Sora Could Be Here This Week' - The Information
Tesla To $370? Here Are 10 Top Analyst Forecasts For Monday
In-Depth Analysis: Microsoft Versus Competitors In Software Industry
Tesla Jumps to Three-year High as Optimus Humanoid Robots Step Into the Spotlight
Tesla Analyst Ratings
What Investors Should Know About David Sacks, Donald Trump's New "AI and Crypto Czar"
Nokia Upgraded on Telco Recovering, Larger Partnership With Microsoft: JP Morgan
Schwab Trading Activity Index Climbs in November, Staying in 'Moderate Low' Range
Today's Pre-Market Movers and Top Ratings | Macy's, Tesla, Workday and More
AMD Falls as BofA Downgrades Amid AI, PC Concerns
Market-Moving News for December 9th
Tesla Model Q Priced Below $30,000 After Subsidies To Reportedly Launch In First Half Of 2025
US Morning News Call | China Investigates Nvidia for Possible Anti-Monopoly Law Violations
Microsoft-G42 Deal Sees US Clear Advanced AI Chips for Export to UAE - Report
Is Tesla Bringing Back Its Media Team? New Job Listing Suggests So, Years After Elon Musk Said Other Companies Spend Money On 'Manipulating Public Opinion'